High Purity 4,7-Dichloroquinoline 99.5%+ for API Synthesis from Japan
Ultra-high purity 4,7-dichloroquinoline (>99.5%) specifically manufactured for active pharmaceutical ingredient synthesis, classified under HTS 2933.49.08.00 as a chemically defined quinoline derivative. Meets stringent pharma intermediate specifications.
Duty Rate — Japan → United States
21%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include CoA with HPLC/GC purity data and heavy metal specifications for FDA/USDA review
• Pre-register with FDA Drug Master File if destined for US pharma production
• GMP manufacturing evidence prevents reclassification as technical grade